Silexion Therapeutics Corp - Warrants(14/08/2029)
SLXNW
Get informed when a big investor buys or sells
+ FollowMarket Cap$152.01K
Close$
Share Statistics
| Market cap | $152,012.00 |
|---|---|
| Enterprise Value | $-666,988.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-89.6 |
| Beta | -0.27 |
| Outstanding Shares | 687,353 |
Return
| Return on Equity | 11668.18% |
|---|---|
| Return on Assets | 120.91% |
| Return on Invested Capital | -1764.00% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.15 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -2.11 |
| Debt to Equity | 32.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-21.20
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 18, 2026
EPS Estimate
$-9.10
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | 26,6830% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 72.43%▼ 104.35% |
|---|---|
| Total Invested | $61,971▼ 25.44% |
| Investors Holding | 21▼ 2.00% |
ESG Score
No data